GoHealth, Inc. (GOCO)
NASDAQFinancialsInsurance - BrokersSnapshot 2026-09-04
$0.30+5.14%
Close 2026-06-15 · 1-day change
NASDAQFinancialsInsurance - BrokersSnapshot 2026-09-04
Broken: Primary pillar broken — Revenue growth from $11.48M current quarter to $261.5M FY26: FY26 guided revenue $70M vs $261.5M target.
GoHealth is restructuring under Chapter 11 to stabilize its finances. The company aims to improve cash flow with new management incentives. Revenue is expected to grow from $11.48 million this quarter to $261.5 million in 2026. If restructuring succeeds, the company could recover from losses.
The bankruptcy filing shows deep financial trouble. Earnings are expected to remain negative through 2027. Delisting risks and management volatility add to uncertainty. The turnaround plan may fail, leading to further value loss.
The market is pricing in severe distress including bankruptcy and restructuring risks. There is no clear consensus on recovery, and estimates show continued losses. Our view aligns with the high risk and uncertain recovery.
Breaks if: Failure to exit Chapter 11 or worsening restructuring status by end of 2026
Complete the voluntary prepackaged Chapter 11 bankruptcy process to restructure ownership and financial foundation.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround situation. The company is currently in a voluntary Chapter 11 restructuring process, which indicates significant financial distress and volatility in management execution.
The market appears to be pricing in a high level of risk, given the company's loss-making status and recent sharp revenue decline. Expectations are low, reflecting the current financial struggles and the need for stabilization.
Fundamentals are likely to remain weak in the near term, as the company faces challenges in meeting liquidity covenants and managing its restructuring process. The recent financial performance has been poor, with a notable drop in revenue and worsening net income.
The long-term thesis hinges on the outcomes of the restructuring process and the ability to maintain liquidity. Additionally, the performance of sector bellwethers like MRSH, AON, and AJG will be crucial, as their success or failure could impact GOCO's recovery prospects.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Newly stated in 2026-Q2. GoHealth initiated a voluntary prepackaged Chapter 11 process with broad support from lenders and equity holders to restructure ownership and financial foundation. Revenue declined sharply from $220.97M in 2025-Q1 to $11.91M in 2026-Q1, and net income worsened from -$4.41M to -$37.17M, reflecting financial distress. The restructuring priority aligns with the financial decline and is a critical step to stabilize the company.
“GoHealth announced voluntary prepackaged Chapter 11 filing to implement restructuring with support from lenders and equity holders.”
Breaks if: EPS loss worsens or remains below -$5.33 in FY26
Breaks if: CEO incentives fail to align with restructuring or performance deteriorates
Breaks if: Revenue falls below $200 million in FY26
Over the next 1 to 3 years, GOCO's path will depend heavily on its restructuring efforts and sector performance. Not investment advice.